127 related articles for article (PubMed ID: 37042432)
21. Impact of metformin on hypothalamic-pituitary-thyroid axis activity in women with autoimmune and non-autoimmune subclinical hypothyroidism: a pilot study.
Krysiak R; Kowalcze K; Okopień B
Pharmacol Rep; 2024 Feb; 76(1):195-206. PubMed ID: 38051473
[TBL] [Abstract][Full Text] [Related]
22. Differences in levothyroxine action on thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity between metformin- and myo-inositol-treated women with autoimmune subclinical hypothyroidism.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharm Ther; 2022 Oct; 47(10):1704-1710. PubMed ID: 35768336
[TBL] [Abstract][Full Text] [Related]
23. Thyroid Antibody Titers and Hypothalamic-Pituitary-Thyroid Axis Activity in Levothyroxine-Treated Women With Autoimmune Subclinical Hypothyroidism Receiving Atorvastatin or Metformin.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharmacol; 2022 Dec; 62(12):1566-1573. PubMed ID: 35852011
[TBL] [Abstract][Full Text] [Related]
24. Impaired Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women with Autoimmune Thyroiditis: A Pilot Study.
Krysiak R; Basiak M; Machnik G; Okopień B
Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513834
[TBL] [Abstract][Full Text] [Related]
25. The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.
Krysiak R; Szkróbka W; Okopień B
Pharmacol Rep; 2021 Feb; 73(1):261-268. PubMed ID: 32696349
[TBL] [Abstract][Full Text] [Related]
26. Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women.
Yavuz D; Deyneli O; Akpinar I; Yildiz E; Gözü H; Sezgin O; Haklar G; Akalin S
Eur J Endocrinol; 2003 Sep; 149(3):187-93. PubMed ID: 12943520
[TBL] [Abstract][Full Text] [Related]
27. Gluten-free diet attenuates the impact of exogenous vitamin D on thyroid autoimmunity in young women with autoimmune thyroiditis: a pilot study.
Krysiak R; Kowalcze K; Okopień B
Scand J Clin Lab Invest; 2022; 82(7-8):518-524. PubMed ID: 36200764
[TBL] [Abstract][Full Text] [Related]
28. Macroprolactinaemia modulates cardiometabolic effects of fenofibrate in men with atherogenic dyslipidaemia: A pilot study.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharm Ther; 2020 Feb; 45(1):115-121. PubMed ID: 31444987
[TBL] [Abstract][Full Text] [Related]
29. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
30. Insulin resistance attenuates the impact of levothyroxine on thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity in women with autoimmune subclinical hypothyroidism.
Krysiak R; Basiak M; Okopień B
Clin Exp Pharmacol Physiol; 2021 Sep; 48(9):1215-1223. PubMed ID: 34062002
[TBL] [Abstract][Full Text] [Related]
31. The Impact of Telmisartan on Cardiometabolic Risk Factors in Hypertensive Male Siblings of Women With Polycystic Ovary Syndrome.
Krysiak R; Basiak M; Szkróbka W; Okopień B
J Clin Pharmacol; 2021 Sep; 61(9):1165-1173. PubMed ID: 33837974
[TBL] [Abstract][Full Text] [Related]
32. The effect of fenofibrate on cardiometabolic risk factors in bromocriptine-treated women with mixed dyslipidemia: A pilot study.
Krysiak R; Okrzesik J; Szkrobka W; Okopień B
Pharmacol Rep; 2016 Feb; 68(1):185-9. PubMed ID: 26721371
[TBL] [Abstract][Full Text] [Related]
33. Different Effects of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Bromocriptine- and Cabergoline-treated Patients with Hashimoto's Thyroiditis and Glucose Metabolism Abnormalities.
Krysiak R; Okrzesik J; Okopien B
Exp Clin Endocrinol Diabetes; 2015 Oct; 123(9):561-6. PubMed ID: 26372847
[TBL] [Abstract][Full Text] [Related]
34. Metabolic effects of dopamine-agonists treatment among patients with prolactinomas.
Kabootari M; Shirmohammadli H; Golgiri F; Mosalamiaghili S; Khajavi A; Akbari H
Endocrine; 2023 Mar; 79(3):537-544. PubMed ID: 36352337
[TBL] [Abstract][Full Text] [Related]
35. Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment.
Pirchio R; Auriemma RS; Solari D; Arnesi M; Pivonello C; Negri M; de Angelis C; Cavallo LM; Cappabianca P; Colao A; Pivonello R
Front Endocrinol (Lausanne); 2021; 12():769744. PubMed ID: 34917030
[TBL] [Abstract][Full Text] [Related]
36. The impact of exogenous vitamin D on thyroid autoimmunity in euthyroid men with autoimmune thyroiditis and early-onset androgenic alopecia.
Krysiak R; Kowalcze K; Okopień B
Pharmacol Rep; 2021 Oct; 73(5):1439-1447. PubMed ID: 34106452
[TBL] [Abstract][Full Text] [Related]
37. Different Cabergoline Effect on Metabolic and Anthropometric Parameters in Female Prolactinoma Patients Versus Idiopathic Hyperprolactinemia Patients.
Aboelnaga MM; Eladawy EH; Elshafei MM; Abdullah N; Shaer ME
Endocr Metab Immune Disord Drug Targets; 2019; 19(4):511-518. PubMed ID: 30806330
[TBL] [Abstract][Full Text] [Related]
38. The impact of combination therapy with metformin and exogenous vitamin D on hypothalamic-pituitary-thyroid axis activity in women with autoimmune thyroiditis and high-normal thyrotropin levels.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharm Ther; 2020 Dec; 45(6):1382-1389. PubMed ID: 32706919
[TBL] [Abstract][Full Text] [Related]
39. Myo-Inositol Potentiates the Inhibitory Effect of Metformin on Prolactin Levels.
Krysiak R; Basiak M; Szkróbka W; Okopień B
Pharmacology; 2023; 108(3):238-244. PubMed ID: 36739860
[TBL] [Abstract][Full Text] [Related]
40. The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy.
Serri O; Li L; Mamputu JC; Beauchamp MC; Maingrette F; Renier G
Clin Endocrinol (Oxf); 2006 Apr; 64(4):366-70. PubMed ID: 16584506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
